TCL Archive In Brief: Breast Cancer Diet Study Problems Resolved, Funding Resumed For Nutrition Coordinator April 19, 1985
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Perot Systems To Provide IT Support For US Oncology Enterprise Applications. December 15, 2000
